Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)
ClinicalTrials.gov study NCT02960555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02095834. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04151615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
ClinicalTrials.gov study NCT00416897. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy
ClinicalTrials.gov study NCT05204160. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT04370483. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05412329. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)
ClinicalTrials.gov study NCT00293111. IPD Sharing: Not stated. Countries: 1. Publications: 0.
UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00113932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00017433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial
ClinicalTrials.gov study NCT05514990. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT00398515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07336823. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00024466. IPD Sharing: NO. Countries: 1. Publications: 0.
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
ClinicalTrials.gov study NCT01697839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov study NCT00054158. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
ClinicalTrials.gov study NCT06429150. IPD Sharing: NO. Countries: 2. Publications: 0.
Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03413800. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01541332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05857982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.